Table 2.
Regression coefficients for log-transformed absolute MAIT cell numbers with respect to clinical and laboratory findings in patients with IBD
| Variables | βa | SE | p value |
|---|---|---|---|
| Sex | −0.054 | 0.254 | 0.832 |
| Age, years | 0.004 | 0.008 | 0.580 |
| IBD activity gradeb | −0.342 | 0.148 | 0.027* |
| Leukocyte count, cells/µL | −0.0001 | 0.000 | 0.287 |
| Lymphocyte count, cells/µL | 0.000 | 0.000 | 0.103 |
| Monocyte count, cells/µL | 0.000 | 0.001 | 0.496 |
| Neutrophil count, cells/µL | −0.0001 | 0.000 | 0.703 |
| Hemoglobin, g/dL | 0.164 | 0.042 | 0.000* |
| Platelet count, ×103 cells/µL | −0.002 | 0.001 | 0.070 |
| Creatinine, mg/dL | 0.003 | 0.009 | 0.750 |
| Total protein, g/dL | 0.003 | 0.018 | 0.849 |
| Albumin, g/dL | −0.082 | 0.077 | 0.298 |
| CRP, mg/dL | −0.062 | 0.028 | 0.033* |
| ESR, mm/h | −0.007 | 0.007 | 0.347 |
IBD, inflammatory bowel disease; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; SE, standard error.
a
Regression coefficient. b Disease activity of Crohn's disease and ulcerative colitis was based on Crohn's Disease Activity Index (CDAI) and Mayo Clinical Index (MCI) for Assessment of Ulcerative Colitis Activity, respectively: grade 1, remission (CDAI <150, MCI <2); grade 2, mild (150≤ CDAI ≤220, 3≤ MCI ≤5); grade 3, moderate (220< CDAI ≤450, 6≤ MCI <10); and grade 4, severe (CDAI >450, MCI ≥10).
*
Statistical significance.